These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study. Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481 [TBL] [Abstract][Full Text] [Related]
23. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study. Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699 [TBL] [Abstract][Full Text] [Related]
24. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Mamdani M; Juurlink DN; Lee DS; Rochon PA; Kopp A; Naglie G; Austin PC; Laupacis A; Stukel TA Lancet; 2004 May; 363(9423):1751-6. PubMed ID: 15172772 [TBL] [Abstract][Full Text] [Related]
25. Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: what is the potential impact of the withdrawal of rofecoxib? Rahme E; Hunsche E; Toubouti Y; Chabot I Arthritis Rheum; 2006 Feb; 55(1):27-34. PubMed ID: 16463408 [TBL] [Abstract][Full Text] [Related]
26. [Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?]. Valat JP; Deray G; Héloire F Presse Med; 2006 Sep; 35 Suppl 1():25-34. PubMed ID: 17870550 [TBL] [Abstract][Full Text] [Related]
27. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta. Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085 [TBL] [Abstract][Full Text] [Related]
28. [Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?]. Valat JP; Deray G; Héloire F Presse Med; 2006 Sep; 35(9 Spec No 1):1S25-34. PubMed ID: 17078592 [TBL] [Abstract][Full Text] [Related]
29. Accounting for the increase in NSAID expenditure: substitution or leakage? Barton GR; Avery AJ; Whynes DK Cost Eff Resour Alloc; 2006 May; 4():9. PubMed ID: 16737538 [TBL] [Abstract][Full Text] [Related]
30. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly? Savage R Drugs Aging; 2005; 22(3):185-200. PubMed ID: 15813652 [TBL] [Abstract][Full Text] [Related]
31. New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study. Wang J; Mullins CD; Mamdani M; Rublee DA; Shaya FT Ann Pharmacother; 2007 Jun; 41(6):937-43. PubMed ID: 17488830 [TBL] [Abstract][Full Text] [Related]
32. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia? Barozzi N; Tett SE Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557 [TBL] [Abstract][Full Text] [Related]
33. What therapies have replaced rofecoxib in Ireland? Teeling M; O'Connor H; Feely J; Bennett K Br J Clin Pharmacol; 2007 Oct; 64(4):536-41. PubMed ID: 17555468 [TBL] [Abstract][Full Text] [Related]
34. Do coxibs reduce prescription of gastroprotective agents? Results of a record linkage study. Formoso G; Menna A; Voci C; Violante A; Magrini N Cost Eff Resour Alloc; 2006 Mar; 4():4. PubMed ID: 16553942 [TBL] [Abstract][Full Text] [Related]
35. A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data. Kasliwal R; Layton D; Harris S; Wilton L; Shakir SA Drug Saf; 2005; 28(9):803-16. PubMed ID: 16119973 [TBL] [Abstract][Full Text] [Related]
36. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. Bally M; Dendukuri N; Rich B; Nadeau L; Helin-Salmivaara A; Garbe E; Brophy JM BMJ; 2017 May; 357():j1909. PubMed ID: 28487435 [No Abstract] [Full Text] [Related]
38. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003 [TBL] [Abstract][Full Text] [Related]
39. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study. Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567 [TBL] [Abstract][Full Text] [Related]
40. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]